This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Bukowski R, Cella D, Gondek K, Escudier B.Effects of sorafenib on symptoms and quality of life: results from a large randomized placebo-controlled study in renal cancer. American Journal of Clinical Oncology 30: 220-227, No. 3, Jun 2007
Rights and permissions
About this article
Cite this article
Sorafenib enhances HRQOL in renal cancer. Pharmacoecon. Outcomes News 533, 1 (2007). https://doi.org/10.1007/BF03296114
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03296114